chr19-18168762-G-A

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BS1BS2

The NM_005027.4(PIK3R2):​c.1845G>A​(p.Pro615Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000138 in 1,549,024 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★). Synonymous variant affecting the same amino acid position (i.e. P615P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000074 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00014 ( 0 hom. )

Consequence

PIK3R2
NM_005027.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: -0.720

Publications

2 publications found
Variant links:
Genes affected
PIK3R2 (HGNC:8980): (phosphoinositide-3-kinase regulatory subunit 2) Phosphatidylinositol 3-kinase (PI3K) is a lipid kinase that phosphorylates phosphatidylinositol and similar compounds, creating second messengers important in growth signaling pathways. PI3K functions as a heterodimer of a regulatory and a catalytic subunit. The protein encoded by this gene is a regulatory component of PI3K. Three transcript variants, one protein coding and the other two non-protein coding, have been found for this gene. [provided by RefSeq, Apr 2019]
PIK3R2 Gene-Disease associations (from GenCC):
  • megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Illumina, G2P, Genomics England PanelApp
  • overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 19-18168762-G-A is Benign according to our data. Variant chr19-18168762-G-A is described in ClinVar as Benign. ClinVar VariationId is 772601.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.72 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0000741 (11/148542) while in subpopulation AMR AF = 0.000267 (4/14976). AF 95% confidence interval is 0.000091. There are 0 homozygotes in GnomAd4. There are 5 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 11 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005027.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PIK3R2
NM_005027.4
MANE Select
c.1845G>Ap.Pro615Pro
synonymous
Exon 15 of 16NP_005018.2
PIK3R2
NR_073517.2
n.2449G>A
non_coding_transcript_exon
Exon 15 of 16
PIK3R2
NR_162071.1
n.2187G>A
non_coding_transcript_exon
Exon 14 of 15

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PIK3R2
ENST00000222254.13
TSL:1 MANE Select
c.1845G>Ap.Pro615Pro
synonymous
Exon 15 of 16ENSP00000222254.6
ENSG00000268173
ENST00000593731.1
TSL:2
n.1845G>A
non_coding_transcript_exon
Exon 15 of 25ENSP00000471914.1
PIK3R2
ENST00000617130.6
TSL:1
n.*873G>A
non_coding_transcript_exon
Exon 14 of 15ENSP00000477864.2

Frequencies

GnomAD3 genomes
AF:
0.0000741
AC:
11
AN:
148408
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000245
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000267
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000214
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000596
Gnomad OTH
AF:
0.000486
GnomAD2 exomes
AF:
0.000493
AC:
121
AN:
245434
AF XY:
0.000293
show subpopulations
Gnomad AFR exome
AF:
0.0000626
Gnomad AMR exome
AF:
0.00293
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000600
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000552
Gnomad OTH exome
AF:
0.000334
GnomAD4 exome
AF:
0.000144
AC:
202
AN:
1400482
Hom.:
0
Cov.:
38
AF XY:
0.000112
AC XY:
78
AN XY:
697016
show subpopulations
African (AFR)
AF:
0.0000631
AC:
2
AN:
31680
American (AMR)
AF:
0.00263
AC:
113
AN:
43044
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23844
East Asian (EAS)
AF:
0.000509
AC:
18
AN:
35346
South Asian (SAS)
AF:
0.0000117
AC:
1
AN:
85674
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
46742
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5516
European-Non Finnish (NFE)
AF:
0.0000578
AC:
62
AN:
1072420
Other (OTH)
AF:
0.000107
AC:
6
AN:
56216
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
14
28
43
57
71
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000741
AC:
11
AN:
148542
Hom.:
0
Cov.:
32
AF XY:
0.0000689
AC XY:
5
AN XY:
72596
show subpopulations
African (AFR)
AF:
0.0000245
AC:
1
AN:
40870
American (AMR)
AF:
0.000267
AC:
4
AN:
14976
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3434
East Asian (EAS)
AF:
0.000214
AC:
1
AN:
4672
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4350
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9912
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000596
AC:
4
AN:
67066
Other (OTH)
AF:
0.000481
AC:
1
AN:
2080
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000181
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

PIK3R2-related disorder Benign:1
Jan 27, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 Benign:1
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Benign
10
DANN
Benign
0.92
PhyloP100
-0.72
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201568661; hg19: chr19-18279572; COSMIC: COSV55847659; COSMIC: COSV55847659; API